Vimarsana
Biggest News Aggregation in the World

Vaxcyte Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vaxcyte Chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vaxcyte Chart Today - Breaking & Trending Today

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Vimarsana News

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Published: February 3, 2024

03.02.2024 - SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) - Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the ...

Source: wallstreet-online.de
Related Topics:
United StatesNew YorkNorth CarolinaJanet GraesserJennifer ZibudaSutro Biopharma IncEvercore GroupProspectus DepartmentGroupa StrepEquity Syndicate DepartmentLeerink PartnersExchange CommissionVaxcyte IncCorporate CommunicationsSyndicate DepartmentBofa SecuritiesTryon StreetEquity Capital MarketsSutro BiopharmaVice PresidentSenior DirectorVaxcyte ChartAxcyte KursAxcyte Aktie
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumococcal Conjugate Vaccines (PCVs) - Vimarsana News

Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumococcal Conjugate Vaccines (PCVs)

Published: October 16, 2023

16.10.2023 - - New Agreement to Establish Global Commercial Manufacturing Capacity for Vaxcyte's PCV Candidates, VAX-24 and VAX-31, in Adult and Pediatric Populations - - Expanded Collaboration Builds on Vaxcyte’s Current Strategy to Conduct Initial Commercial ... Seite 1

Source: wallstreet-online.de
Related Topics:
Switzerland GeneralVaxcyte IncStage Clinical DevelopmentStanding Relationship BetweenCompanies Further EnhancedVaxcyte Progresses Lead Vaccine CandidateLate Stage ClinicalNew Purpose Built Large Scale Manufacturing SuiteIbex DedicateIbex Dedicate BioparkChief Executive OfficerVaxcyte ChartAxcyte KursAxcyte Aktie